Castellan Group, LLC
- SEC CIK
- 0001832521
- Latest filing
- Jul 23, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Castellan Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −29,276−100.0% | Sold out | Holders |
| Q3 2024 | 29,276 | $3.49M | 1.5% | −13,195−31.1% | Reduced | Holders |
| Q2 2024 | 42,471 | $6.06M | 2.9% | +2,162+5.4% | Added | Holders |
| Q1 2024 | 40,309 | $5.18M | 2.6% | −3,598−8.2% | Reduced | Holders |
| Q4 2023 | 43,907 | $4.54M | 2.8% | +3,032+7.4% | Added | Holders |
| Q3 2023 | 40,875 | $3.72M | 2.6% | −3,873−8.7% | ReducedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 22,374 | $3.62M | 2.3% | −3,391−13.2% | Reduced | Holders |
| Q1 2023 | 25,765 | $4.10M | 2.8% | −2,260−8.1% | Reduced | Holders |
| Q4 2022 | 28,025 | $3.79M | 2.6% | −305−1.1% | Reduced | Holders |
| Q3 2022 | 28,330 | $2.82M | 2.2% | −2,285−7.5% | Reduced | Holders |
| Q2 2022 | 30,615 | $3.41M | 2.7% | −1,310−4.1% | Reduced | Holders |
| Q1 2022 | 31,925 | $3.54M | 2.5% | +3,305+11.5% | Added | Holders |
| Q4 2021 | 28,620 | $3.21M | 2.2% | +6,700+30.6% | Added | Holders |
| Q3 2021 | 21,920 | $2.10M | 1.1% | +21,920 | New | Holders |